NCT03349580 is a NA clinical trial of The training group in Lumbar Spine Fusion, sponsored by Dejan Kernc.

Who is sponsoring NCT03349580?

NCT03349580 is sponsored by Dejan Kernc.

What drugs are being tested in NCT03349580?

Interventions in NCT03349580: The training group.

What condition does NCT03349580 study?

NCT03349580 studies Lumbar Spine Fusion.

Is NCT03349580 still recruiting?

NCT03349580 is currently completed. Last updated 24 November 2017.

Last reviewed 2017-11-24 · How we verify

NCT03349580

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Initiation of a Strength Training Based Rehabilitation After Lumbar Spine Fusion Improves Core Muscle Strength

Completed NA Last updated 24 November 2017

What this trial tests

NA trial testing The training group in Lumbar Spine Fusion in 27 participants. Completed in 15 September 2017.

Timeline

4 April 2014

Primary endpoint
25 November 2016

15 September 2017

Quick facts

Lead sponsor	Dejan Kernc
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	27
Start date	4 April 2014
Primary completion	25 November 2016
Estimated completion	15 September 2017

Drugs / interventions tested

The training group

Conditions studied

Lumbar Spine Fusion — all drugs for Lumbar Spine Fusion →

Sponsor

Dejan Kernc

Who can join

Adults 45 to 70, any sex, with Lumbar Spine Fusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To analyze safety and the effects of early initiation of the rehabilitation. Including the objective measurement outcomes after lumbar spine fusion, based on the principles of strength training.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Early initiation of a strength training based rehabilitation after lumbar spine fusion improves core muscle strength: a randomized controlled trial.
Kernc D, Strojnik V, Vengust R. · · 2018 · cited 29× · PMID 29914580 · DOI 10.1186/s13018-018-0853-7

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03349580 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dejan Kernc
Last refreshed: 24 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03349580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing